The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05803759
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT05803759
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT05803759. Randomized; double masking; primary purpose treatment. Start 2023-04-10 (actual); primary completion 2024-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
- Acronym
- TEA-CART
- Condition
- Myocardial Ischemia
- Condition
- Coronary Artery Bypass Grafting
- Condition
- Coronary Arteriosclerosis
- Condition
- Percutaneous Coronary Revascularization
- Intervention (Dietary supplement)
- Allicor
- Intervention (Drug)
- Placebo
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
Record details
- Record id
cardio:ct-nct05803759- Content hash
0c79fd7f3877e4313393c310b62396a9ecb3568704eaa84eca4112feba53a542